Submission date
30/09/2005
Registration date
30/09/2005
Last edited
18/11/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Retrospectively registered
? Protocol not yet added
? SAP not yet added
? Results not yet added and study completed for more than 2 years
? Raw data not yet added
Study completed

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Dr Jervoise Andreyev

ORCID ID

Contact details

Medicine Section
Royal Marsden NHS Trust
Downs Road
Sutton
Surrey
SM2 5PT
United Kingdom
+44 (0)20 8643 8901

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

N0258127574

Study information

Scientific title

Acronym

Study hypothesis

To determine the effectiveness of normacol for treating faecal incontinence.

Ethics approval(s)

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Study setting(s)

Hospital

Study type

Treatment

Patient information sheet

Condition

Faecal incontinence

Intervention

Normacol versus placebo.

Intervention type

Drug

Pharmaceutical study type(s)

Phase

Not Specified

Drug/device/biological/vaccine name(s)

Normacol

Primary outcome measure

Would be the first study of any kind to report benefit for any treatment in this group of patients with this condition.

Secondary outcome measures

Not provided at time of registration

Overall study start date

01/07/2003

Overall study end date

30/05/2007

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

Any patient with episodes of active or passive faecal incontinence one or more per month at least 3 months after the completion of pelvic radiotherapy who did not have pre-existing incontinence.

Participant type(s)

Patient

Age group

Not Specified

Sex

Not Specified

Target number of participants

Not provided at time of registration

Participant exclusion criteria

1. Patients unlikely to survive 1 year
2. Patients unable to give informed consent

Recruitment start date

01/07/2003

Recruitment end date

30/05/2007

Locations

Countries of recruitment

England, United Kingdom

Study participating centre

Medicine Section
Sutton, Surrey
SM2 5PT
United Kingdom

Sponsor information

Organisation

Department of Health

Sponsor details

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
+44 (0)20 7307 2622
dhmail@doh.gsi.org.uk

Sponsor type

Government

Website

http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Funder name

The Royal Marsden NHS Foundation Trust (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Funder name

NHS R&D Support Funding (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?

Additional files

Editorial Notes